Barclays Maintains an 'Equalweight' on Eli Lilly (LLY); Review of Solanezumab Results

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 8/18/2026

1. SPY
2. EYPT
3. NVDA
4. TSLA
5. ARGX
6. USO
7. AWK
8. GNK
9. HD
10. MU

Go back to Barclays Maintains an 'Equalweight' on Eli Lilly (LLY); Review of Solanezumab Results
Lilly (Eli) & Co. (NYSE: LLY) Delayed: 1183.16 --0 (-0%)
Previous Close $1183.16    52 Week High $88.16 
Open $1183.16    52 Week Low $67.88 
Day High $1183.16    P/E 273.88 
Day Low $1183.16    EPS $4.32 
Volume 2,711